Source: Nasdaq

Abbott: Slower Nutrition And Diagnostics Weighed On Abbott In Q1; What To Watch For Q2

(RTTNews) - Abbott (ABT) will report second-quarter 2026 financial results on Thursday, July 16, 2026, before the market opens, with investors focused on whether momentum in Medical Devices and the newly added oncology diagnostics business can offset lingering softness in Nutriti

Read full article »
Annual Revenue
$10-50B
Employees
100K-9.9M
Robert B. Ford's photo - Chairman & CEO of Abbott

Chairman & CEO

Robert B. Ford

CEO Approval Rating

84/100

Read more